Showing results (1-10 of 499) with videos related to
Sort By:
Pageof 50
Medizinische Klinik (Munich, Germany : 1983)|February 3, 2006
[Antihypertensive drug utilization in obese patients]Peter Bramlage, Carsten Bramlage, Wilhelm KirchClinical Drug Investigation|September 7, 2007
Cardiovascular risk in obese hypertensive patients taking various antihypertensive drugsChristoph Schindler, Peter Bramlage, Martin Thoenes, et al.Clinical Drug Investigation|May 30, 2007
Antihypertensive effect of irbesartan and predictors of response in obesity-associated hypertension : a prospective, open-label studyArya M Sharma, Peter Bramlage, Wilhelm KirchCurrent Medical Research and Opinion|April 5, 2007
Clinical practice and recent recommendations in hypertension management--reporting a gap in a global survey of 1259 primary care physicians in 17 countriesPeter Bramlage, Martin Thoenes, Wilhelm Kirch, et al.Expert Opinion on Drug Safety|February 16, 2005
Drug interactions with angiotensin receptor blockersSteffen Böhler, David Pittrow, Peter Bramlage, et al.Vascular Health and Risk Management|June 23, 2007
Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapyChristoph Schindler, Peter Bramlage, Wilhelm Kirch, et al.Blood Pressure Monitoring|January 20, 2025
Validation of the Microlife BP3T01-1B blood pressure monitoring device in adults and adolescents according to the ISO 81060-2:2018 protocolBeate Botta, Carsten Bramlage, Violetta Hachaturyan, et al.Angiology|October 12, 2007
Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept studyChristoph Schindler, Axel Mueller, Peter Bramlage, et al.Herz|November 1, 2007
[Prevention of cardiovascular disease by blocking the endocannabinoid system]Peter Bramlage, Christoph Schindler, Martin Thoenes, et al.Future Cardiology|October 7, 2009
Albuminuria: pathophysiology, epidemiology and clinical relevance of an emerging marker for cardiovascular diseaseMartin Thoenes, Peter Bramlage, Bobby V Khan, et al.Pageof 50